Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 24321-24330 Newer>

The Motley Fool July 6, 2007 Rick Aristotle Munarriz	Dueling Fools: Salesforce.com Bear Rebuttal The company needs to expand into other software categories to keep revving the growth. If that doesn't raise red flags, then you probably deserve what you get if you buy into Salesforce at these high prices.
The Motley Fool July 6, 2007	Sagging Sales at Bassett Furniture: Fool by Numbers The furniture maker and retailer released earnings for the second-quarter 2007: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool July 6, 2007 Tom Taulli	Score One for Oracle The battle continues among the software giants, as SAP makes a surprising admission. The main thing for investors to consider is that Oracle has a clear strategy for growth: buying up companies.
The Motley Fool July 6, 2007 Brian Lawler	Elan Goes to the Isles The drugmaker wins an important battle in the U.K., but shares are still priced for more than perfection.
The Motley Fool July 6, 2007 Timothy M. Otte	Drugstore Sales Remain Healthy The big four drugstore chains report higher comparable sales in June. Walgreen... CVS... Rite Aid... Long's...
The Motley Fool July 6, 2007 Rich Duprey	Become Your Own Arbitrageur A couple of stocks for sale offer investors the chance to beat the Street at its own game. Chipotle Mexican Grill... Mueller Water...
The Motley Fool July 6, 2007 Brian Lawler	Another Round for Alkermes' Alcohol Fight Alkermes advances the development of another drug. Investors, take note.
The Motley Fool July 6, 2007 Billy Fisher	Private Equity Turns Focus to Nursing Homes Manor Care will go private in an all-cash deal. Investors, take note.
The Motley Fool July 6, 2007 Rick Aristotle Munarriz	From Craigslist to Megslist Investors, why is eBay trying to launch a potential Craigslist killer that may ultimately inflict harm on eBay.com itself? If you're scratching your head for the answer, you're missing the ominous trends.
The Motley Fool July 6, 2007 Billy Fisher	Medtronic: For the Broken-Hearted Promising clinical trial could bring a new Medtronic stent to market. Investors, take note.
<Older 24321-24330 Newer> Return to current articles.